# Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly

**Authors:** Vivian Schultz, Benita Schmitz-Koep, Aurore Menegaux, Melissa Thalhammer, Severin Schramm, Su Hwan Kim, Claus Zimmer, Christian Sorg, Panteleimon Giannakopoulos, Marie-Louise Montandon, François R. Herrmann, Cristelle Rodriguez, Sven Haller, Dennis M. Hedderich

PMC · DOI: 10.3389/fnagi.2025.1542857 · Frontiers in Aging Neuroscience · 2025-07-16

## TL;DR

This study shows that lower hippocampal volume in healthy elderly people at baseline is linked to faster volume loss over time.

## Contribution

The study reveals a novel association between baseline hippocampal z-scores and subsequent atrophy rates in healthy aging.

## Key findings

- Hippocampal volumes decreased over time with a mean annualized percent change of -1.34% (right) and -1.79% (left).
- Lower baseline hippocampal z-scores correlated with higher volume loss rates (right r = 0.17, left r = 0.14).
- No covariates significantly influenced the observed association between baseline volumes and atrophy rates.

## Abstract

Hippocampal volume loss occurs physiologically with age, but an accelerated rate of volume loss is linked to neurodegenerative diseases. While evidence suggests that cross-sectional study designs tend to underestimate hippocampal atrophy rates compared to longitudinal approaches, few studies have directly examined the relationship between these two methods in the context of brain aging. This study aims to investigate the association between baseline hippocampal z-scores and hippocampal volume loss over time in a cohort of healthy older adults.

182 healthy elderly subjects (mean age: 73.4 ± 3.5 years) who underwent structural Magnetic resonance imaging (MRI) at two timepoints (mean time between the scans 4.8 ± 1.0 years) were included. A subset of participants (n = 103) also completed Positron emission tomography (PET) amyloid imaging. Hippocampal volumes were measured at baseline and follow-up using FreeSurfer (v7.1.1). Baseline volumes were adjusted for age and intracranial volume (ICV) and converted into z-scores. The annualized percent change (APC) in hippocampal volume was calculated for each participant. Neuropsychological assessments were conducted at baseline, 18, and 54 months, and APOE genotyping was performed. Correlation analyses examined the relationship between baseline hippocampal volumes and APC, while multiple regression models explored potential influencing factors.

Hippocampal volumes decreased from baseline to follow-up [mean APC (SD): right −1.34% (0.94), left: −1.79% (1.00)]. Small, but statistically significant positive correlations were found between baseline hippocampal z-scores and APC of hippocampal volumes over time, indicating that the lower the volume at baseline, the greater the atrophy rate to timepoint two (right hippocampus: r = 0.17, p = 0.01; left hippocampus: r = 0.14, p = 0.03). No covariates significantly influenced this association (p > 0.05).

Lower baseline hippocampal z-scores are associated with a greater rate of hippocampal atrophy to the follow-up examination. If validated in larger cohorts, these findings could help establish cut-off values for pathological atrophy in cross-sectional studies.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348]

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** AD (MESH:D000544), volume loss (MESH:D016388), brain lesions (MESH:D001927), neurologic disorders (MESH:D009461), cognitive complaints (MESH:D003072), neurofibrillary (MESH:D055956), stroke (MESH:D020521), hippocampal volume loss (MESH:D000092223), cardiac illness (MESH:D006331), head injury (MESH:D006259), neoplasm (MESH:D009369), structural deficits (MESH:D020914), Anxiety (MESH:D001007), MCI (MESH:D060825), Depression (MESH:D003866), PET (MESH:D014012), Dementia (MESH:D003704), neurodegeneration (MESH:D019636), alcohol or drug abuse (MESH:D019966), brain atrophy (MESH:C566985), Hippocampal atrophy (MESH:D001284), psychiatric (MESH:D001523), amyloid (MESH:C000718787)
- **Chemicals:** 18F-Flutemetamol (MESH:C581552), 18F-Florbetapir (MESH:C545186)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307302/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12307302/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307302/full.md

---
Source: https://tomesphere.com/paper/PMC12307302